James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Should You Still Hold HPQ After the Hewlett-Packard Split?

The HPQ you own today isn't the same HPQ you owned just a few days ago. Here's how things shake out after the split.

Tesla Stock: What to Know Before Tuesday’s Report

Tesla stock has been particularly disappointing since September. Will the third-quarter's earnings call make things better, or worse?

Why SolarCity Corp (SCTY), CVS Health Corp (CVS) and Valeant Pharmaceuticals Intl Inc (VRX) Are 3 of Today’s Worst Stocks

SolarCity (SCTY), CVS Health (CVS) and Valeant Pharmaceuticals (VRX) each used more than their fair share of red ink on Friday.

BIDU Stock Looks Good (Albeit Tricky) After the Baidu Earnings News

BIDU stock is soaring, and understandably so, after the Baidu earnings report for Q3. Here's everything investors need to know.

10 Scarily Overbought Stocks to Sell

These stocks are all riding a wave of bullish momentum, but those waves are about to come crashing down very soon.